{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_015482.3:c.926G>A (p.G309D)",
          "cDNA Change": {
            "transcript": "NM_015482.3",
            "ref": "G",
            "alt": "A",
            "position": "926"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "309"
          },
          "Description in input context": "c.926G>A (p.G309D)"
        }
      ]
    },
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_015482.3:c.1039C>T (p.L347P)",
          "cDNA Change": {
            "transcript": "NM_015482.3",
            "ref": "C",
            "alt": "T",
            "position": "1039"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "P",
            "position": "347"
          },
          "Description in input context": "c.1039C>T (p.L347P)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Recessive parkinsonism",
    "MONDO": "MONDO:0002854"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro kinase activity assay",
      "Material used": {
        "Material Source": "Mammalian cells",
        "Material Name": "Transfected cells with PINK1 constructs",
        "Description": "PINK1 constructs tagged with myc or GFP were transfected into mammalian cells."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_015482.3:c.926G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No significant effect on kinase activity.",
          "Result Description": "The G309D mutation did not significantly affect kinase activity."
        },
        {
          "Variant": "NM_015482.3:c.1039C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity and stability.",
          "Result Description": "The L347P mutation resulted in reduced kinase activity and protein stability."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal kinase activity levels as per wild-type PINK1.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced kinase activity compared to wild-type, indicating potential pathogenicity.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "In vitro kinase assays and protein localization studies are standard methods used in studying PINK1 function and its role in parkinsonism."
      }
    }
  ]
}